Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Anil Londhe »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anil Kaul < Anil Londhe < Anil Nooka  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
001006 (2015) Fred Saad [Canada] ; Neal Shore [États-Unis] ; Hendrik Van Poppel [Belgique] ; Dana E. Rathkopf [États-Unis] ; Matthew R. Smith [États-Unis] ; Johann S. De Bono [Royaume-Uni] ; Christopher J. Logothetis [États-Unis] ; Paul De Souza [Australie] ; Karim Fizazi [France] ; Peter F. A. Mulders [Pays-Bas] ; Paul Mainwaring [Australie] ; John D. Hainsworth [États-Unis] ; Tomasz M. Beer [États-Unis] ; Scott North [Canada] ; Yves Fradet [Canada] ; Thomas A. Griffin [États-Unis] ; Peter De Porre [Belgique] ; Anil Londhe [États-Unis] ; Thian Kheoh [États-Unis] ; Eric J. Small [États-Unis] ; Howard I. Scher [États-Unis] ; Arturo Molina [États-Unis] ; Charles J. Ryan [États-Unis]Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Abiraterone Acetate (adverse effects)
1Abiraterone Acetate (therapeutic use)
1Aged
1Antineoplastic Agents, Hormonal (adverse effects)
1Antineoplastic Agents, Hormonal (therapeutic use)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Bisphosphonate-Associated Osteonecrosis of the Jaw (etiology)
1Bone Density Conservation Agents (adverse effects)
1Bone Density Conservation Agents (therapeutic use)
1Bone Neoplasms (drug therapy)
1Bone Neoplasms (mortality)
1Bone Neoplasms (secondary)
1Clinical Trials, Phase III as Topic
1Disease-Free Survival
1Humans
1Kaplan-Meier Estimate
1Male
1Middle Aged
1Multicenter Studies as Topic
1Odds Ratio
1Prednisone (therapeutic use)
1Proportional Hazards Models
1Prostatic Neoplasms, Castration-Resistant (drug therapy)
1Prostatic Neoplasms, Castration-Resistant (mortality)
1Prostatic Neoplasms, Castration-Resistant (pathology)
1Randomized Controlled Trials as Topic
1Retrospective Studies
1Risk Factors
1Steroid Synthesis Inhibitors (adverse effects)
1Steroid Synthesis Inhibitors (therapeutic use)
1Time Factors
1Treatment Outcome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Anil Londhe" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Anil Londhe" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Anil Londhe
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024